Free Trial

Bank Julius Baer & Co. Ltd Zurich Grows Stock Holdings in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background
Remove Ads

Bank Julius Baer & Co. Ltd Zurich lifted its position in Xylem Inc. (NYSE:XYL - Free Report) by 139.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 436,415 shares of the industrial products company's stock after acquiring an additional 254,074 shares during the period. Bank Julius Baer & Co. Ltd Zurich owned 0.18% of Xylem worth $53,991,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in XYL. Heck Capital Advisors LLC purchased a new stake in shares of Xylem during the fourth quarter worth $36,000. SRS Capital Advisors Inc. boosted its holdings in shares of Xylem by 69.5% during the 4th quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock worth $37,000 after purchasing an additional 130 shares during the last quarter. Pathway Financial Advisers LLC grew its position in shares of Xylem by 122.4% in the fourth quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock valued at $37,000 after purchasing an additional 175 shares in the last quarter. Assetmark Inc. increased its holdings in shares of Xylem by 3,887.5% in the third quarter. Assetmark Inc. now owns 319 shares of the industrial products company's stock valued at $43,000 after purchasing an additional 311 shares during the last quarter. Finally, Versant Capital Management Inc lifted its position in Xylem by 318.2% during the fourth quarter. Versant Capital Management Inc now owns 368 shares of the industrial products company's stock worth $43,000 after buying an additional 280 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Xylem Trading Down 0.5 %

Shares of XYL traded down $0.64 during midday trading on Wednesday, hitting $122.99. 1,117,979 shares of the stock were exchanged, compared to its average volume of 1,204,466. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76. The firm has a market cap of $29.89 billion, a P/E ratio of 33.60, a P/E/G ratio of 2.33 and a beta of 1.08. Xylem Inc. has a 52-week low of $113.26 and a 52-week high of $146.08. The stock has a fifty day simple moving average of $124.39 and a 200 day simple moving average of $126.86.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.12 by $0.06. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.18 billion. During the same period in the prior year, the firm earned $0.99 earnings per share. The business's revenue for the quarter was up 8.6% compared to the same quarter last year. On average, research analysts anticipate that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 19th. Investors of record on Tuesday, February 18th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Tuesday, February 18th. This is a positive change from Xylem's previous quarterly dividend of $0.36. This represents a $1.60 dividend on an annualized basis and a yield of 1.30%. Xylem's dividend payout ratio (DPR) is 43.72%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on XYL shares. Wolfe Research reaffirmed a "peer perform" rating on shares of Xylem in a research note on Thursday, December 12th. Robert W. Baird raised their price objective on shares of Xylem from $139.00 to $148.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 5th. Citigroup lowered shares of Xylem from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 5th. Finally, Stifel Nicolaus reduced their price target on shares of Xylem from $166.00 to $150.00 and set a "buy" rating on the stock in a research report on Friday, January 24th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $149.90.

Get Our Latest Research Report on XYL

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads